Age: 63.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Erythema, Heart rate increased, Neuropathy peripheral
Clinical narrative: neuropathy in her right hand; Heart rate of 150; cough; hair loss; red spots on face; no appetite; GI upset; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (neuropathy in her right hand) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product TUCATINIB (TUKYSA) for Neoplasm breast.    Concurrent medical conditions included Malignant neoplasm of female breast.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and TUCATINIB (TUKYSA) (unknown route) at an unspecified dose. On an unknown date, the patient experienced NEUROPATHY PERIPHERAL (neuropathy in her right hand) (seriousness criterion medically significant), HEART RATE INCREASED (Heart rate of 150), COUGH (cough), ALOPECIA (hair loss), ERYTHEMA (red spots on face), DECREASED APPETITE (no appetite) and ABDOMINAL DISCOMFORT (GI upset). At the time of the report, NEUROPATHY PERIPHERAL (neuropathy in her right hand), HEART RATE INCREASED (Heart rate of 150), COUGH (cough), ALOPECIA (hair loss), ERYTHEMA (red spots on face), DECREASED APPETITE (no appetite) and ABDOMINAL DISCOMFORT (GI upset) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Blood bilirubin: elevated (High) Elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.  On 12-MAR-2021, it was reported that the patient was in the emergency room (ER). She was complaining of heart rate of 150 and cough. She states, "I got Moderna Vaccine the day before I started my Tukysa, I am not sure which one or both are doing this.  On 03-MAY-2021, it was reported that Patient reports that Tukysa was on hold for about a week from 16-APR-2021 to 22-APR-2021 because her bilirubin level was elevated. Patient reports that she also has little red spots on her face, they do not itch and are not painful. Patient states that she has no appetite and has a lot of GI upset. Patient states that she is beginning to lose her hair. Patient also states that she had some neuropathy in her R hand.  This case refers to a 63-yearold female patient receiving cancer treatment who experienced some events after the administration of the vaccine on an unspecified date. Very limited information regarding these events has been provided at this time. Further information has been requested.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: additional adverse events were updated, case upgraded to serious, action taken with Tukysa was updated.; Sender's Comments: This case refers to a 63-yearold female patient receiving cancer treatment who experienced some events after the administration of the vaccine on an unspecified date. Very limited information regarding these events has been provided at this time. Further information has been requested.